Synergistic growth inhibitory effect of deracoxib with doxorubicin against a canine mammary tumor cell line, CMT-U27

Cyclooxygenase (COX) inhibitors have been shown to exert anti-angiogenic and anti-tumor activities on many types of malignant tumors. These anticancer properties make it worthwhile to examine the possible benefit of combining COX inhibitors with other anti-cancer agents. In the present study, we eva...

Descripción completa

Detalles Bibliográficos
Autores principales: BAKIREL, Tülay, ALKAN, Fulya Üstün, ÜSTÜNER, Oya, ÇINAR, Suzan, YILDIRIM, Funda, ERTEN, Gaye, BAKIREL, Utku
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Veterinary Science 2016
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4873858/
https://www.ncbi.nlm.nih.gov/pubmed/26822118
http://dx.doi.org/10.1292/jvms.15-0387

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4873858/
https://www.ncbi.nlm.nih.gov/pubmed/26822118
http://dx.doi.org/10.1292/jvms.15-0387

Ejemplares similares